APA Zitierstil

Harrer, A., Pilz, G., Oppermann, K., Sageder, M., Afazel, S., Haschke-Becher, E., . . . Wipfler, P. (2017). From natalizumab to fingolimod in eight weeks - Immunological, clinical, and radiological data in quest of the optimal switch. Clinical immunology (Orlando, Fla.), 176, 87. https://doi.org/10.1016/j.clim.2017.01.001

Chicago Zitierstil

Harrer, Andrea, et al. "From Natalizumab to Fingolimod in Eight Weeks - Immunological, Clinical, and Radiological Data in Quest of the Optimal Switch." Clinical Immunology (Orlando, Fla.) 176 (2017): 87. https://dx.doi.org/10.1016/j.clim.2017.01.001.

MLA Zitierstil

Harrer, Andrea, et al. "From Natalizumab to Fingolimod in Eight Weeks - Immunological, Clinical, and Radiological Data in Quest of the Optimal Switch." Clinical Immunology (Orlando, Fla.), vol. 176, 2017, p. 87.